A detailed history of Fmr LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Fmr LLC holds 7,814,996 shares of ALXO stock, worth $17.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,814,996
Previous 7,522,812 3.88%
Holding current value
$17.3 Million
Previous $83.9 Million 43.82%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.84 - $17.56 $1.71 Million - $5.13 Million
292,184 Added 3.88%
7,814,996 $47.1 Million
Q1 2024

May 13, 2024

BUY
$10.95 - $16.79 $547,401 - $839,348
49,991 Added 0.67%
7,522,812 $83.9 Million
Q4 2023

Feb 13, 2024

BUY
$4.81 - $15.38 $9.05 Million - $28.9 Million
1,880,874 Added 33.64%
7,472,821 $111 Million
Q3 2023

Nov 13, 2023

SELL
$4.19 - $7.35 $2.26 Million - $3.96 Million
-538,592 Reduced 8.79%
5,591,947 $26.8 Million
Q2 2023

Aug 11, 2023

BUY
$4.37 - $9.56 $4,798 - $10,496
1,098 Added 0.02%
6,130,539 $46 Million
Q1 2023

May 11, 2023

BUY
$4.52 - $11.71 $72,378 - $187,512
16,013 Added 0.26%
6,129,441 $27.7 Million
Q4 2022

Feb 13, 2023

BUY
$9.51 - $12.95 $14.1 Million - $19.2 Million
1,482,854 Added 32.02%
6,113,428 $68.9 Million
Q3 2022

Nov 10, 2022

BUY
$8.23 - $15.14 $5.3 Million - $9.76 Million
644,360 Added 16.16%
4,630,574 $44.3 Million
Q2 2022

Aug 12, 2022

BUY
$5.89 - $19.46 $2.52 Million - $8.31 Million
427,260 Added 12.01%
3,986,214 $32.2 Million
Q1 2022

May 13, 2022

BUY
$13.65 - $22.06 $13.2 Million - $21.3 Million
966,015 Added 37.26%
3,558,954 $60.1 Million
Q4 2021

Feb 14, 2022

BUY
$21.49 - $74.4 $28.7 Million - $99.2 Million
1,333,523 Added 105.88%
2,592,939 $55.7 Million
Q3 2021

Nov 15, 2021

SELL
$52.51 - $80.91 $239,288 - $368,706
-4,557 Reduced 0.36%
1,259,416 $93 Million
Q2 2021

Aug 13, 2021

BUY
$52.2 - $75.23 $66 Million - $95.1 Million
1,263,973 New
1,263,973 $69.1 Million

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $90.5M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.